Methylene blue is a guanylate cyclase inhibitor that does not interfere with nitric oxide synthesis. [Carta] (2016)
- Autor:
- Autor USP: EVORA, PAULO ROBERTO BARBOSA - FMRP
- Unidade: FMRP
- DOI: 10.14503/THIJ-15-5629
- Subjects: ÓXIDO NÍTRICO; FÁRMACOS (SISTEMA CARDIOVASCULAR); DOENÇAS VASCULARES
- Language: Inglês
- Imprenta:
- Source:
- Título: Texas Heart Institute Journal
- ISSN: 0730-2347
- Volume/Número/Paginação/Ano: v. 43, n. 1, p. 103, 2016
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: green
-
ABNT
EVORA, Paulo Roberto Barbosa. Methylene blue is a guanylate cyclase inhibitor that does not interfere with nitric oxide synthesis. [Carta]. Texas Heart Institute Journal. Houston: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.14503/THIJ-15-5629. Acesso em: 29 dez. 2025. , 2016 -
APA
Evora, P. R. B. (2016). Methylene blue is a guanylate cyclase inhibitor that does not interfere with nitric oxide synthesis. [Carta]. Texas Heart Institute Journal. Houston: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.14503/THIJ-15-5629 -
NLM
Evora PRB. Methylene blue is a guanylate cyclase inhibitor that does not interfere with nitric oxide synthesis. [Carta] [Internet]. Texas Heart Institute Journal. 2016 ; 43( 1): 103.[citado 2025 dez. 29 ] Available from: https://doi.org/10.14503/THIJ-15-5629 -
Vancouver
Evora PRB. Methylene blue is a guanylate cyclase inhibitor that does not interfere with nitric oxide synthesis. [Carta] [Internet]. Texas Heart Institute Journal. 2016 ; 43( 1): 103.[citado 2025 dez. 29 ] Available from: https://doi.org/10.14503/THIJ-15-5629 - Endothelium dysfunction classification: why is it still an open discussion?.[Carta]
- Asymmetric dimethylarginine endogenous inhibition of nitric oxide synthase causes differential vasculature effects
- Letter by Gomes and Evora regarding article, "Early on-cardiopulmonary bypass hypotension and other factors associated with vasoplegic syndrome" [Carta]
- Mitral stenosis acute pulmonary edema and rheumatic fever pneumonitis: a hypothesis to an old enigma [carta]
- High conductance potassium channels activation by acid exposure in rat aorta is endothelium-dependent
- Biological aortic heart valve prosthesis in patients under 65 years old. [Carta]: are the paradigms changing ?
- Cardiopulmonary bypass in myocardial revascularization surgery in the State of São Paulo [Editorial]: the REPLICCAR study
- G-proteins agonists and NO/cGMP blockers [Editorial]: unexplored frontiers in the pharmaceutical industry
- Thirtieth anniversary of the Brazilian Journal of Cardiovascular Surgery. And devising the next decades. [Editorial]
- Is the cardiopulmonary bypass systemic inflammatory response overestimated ?. [Editorial]
Informações sobre o DOI: 10.14503/THIJ-15-5629 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
